Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1985 Feb;61(1):44–47. doi: 10.1136/sti.61.1.44

Two regimens of sultamicillin in treating uncomplicated gonorrhoea.

C Farthing, R N Thin, S Smith, I Phillips
PMCID: PMC1011754  PMID: 3002961

Abstract

Sultamicillin is a covalent union of ampicillin and the beta lactamase inhibitor, sulbactam (CP-45,899). Two studies were conducted to assess its efficacy in treating uncomplicated gonorrhoea. In the first study treatment comprised sultamicillin 1.5 g and probenecid 1 g; 124 (89.2%) of 139 patients responded including seven of 11 patients harbouring beta lactamase (penicillinase) producing strains of Neisseria gonorrhoeae (PPNG). In the second study sultamicillin 2.25 g and probenecid 1 g were given; 122 (93.8%) of 130 patients responded. Only two of seven pharyngeal infections resolved, and if pharyngeal infections are excluded the overall cure rate rose to 95.3%. Thirteen of 14 patients infected with PPNG strains were cured by the larger dose. Side effects were mild and transitory. It may be concluded that sultamicillin 2.25 g plus probenecid 1 g is an effective regimen to treat uncomplicated rectal and genital gonorrhoea and is useful for treating infections with PPNG strains. Most beta lactamase resistant antimicrobials must be given parenterally; sultamicillin is given by mouth.

Full text

PDF
44

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler M. W. Diagnostic treatment and reporting criteria for gonorrhoea in sexually transmitted disease clinics in England and Wales. 2: treatment and reporting criteria. Br J Vener Dis. 1978 Feb;54(1):15–23. doi: 10.1136/sti.54.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atia W. A., Emmerson A. M., Holmes D. Sultamicillin in the treatment of gonorrhoea caused by penicillin sensitive and penicillinase producing strains of Neisseria gonorrhoeae. Br J Vener Dis. 1983 Oct;59(5):293–297. doi: 10.1136/sti.59.5.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Easmon C. S., Ison C. A., Bellinger C. M., Harris J. W. Emergence of resistance after spectinomycin treatment for gonorrhoea due to beta-lactamase producing strain of Neisseria gonorrhoeae. Br Med J (Clin Res Ed) 1982 May 29;284(6329):1604–1605. doi: 10.1136/bmj.284.6329.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Panikabutra K., Ariyarit C., Chitwarakorn A., Saensanoh C. Cefaclor and cefamandole as alternatives to spectinomycin in the treatment of men with uncomplicated gonorrhoea. Br J Vener Dis. 1983 Oct;59(5):298–301. doi: 10.1136/sti.59.5.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Phillips I. Beta-lactamase-producing, penicillin-resistant gonococcus. Lancet. 1976 Sep 25;2(7987):656–657. doi: 10.1016/s0140-6736(76)92466-1. [DOI] [PubMed] [Google Scholar]
  6. Phillips I., Humphrey D., Middleton A., Nicol C. S. Diagnosis of gonorrhoea by culture on a selective medium containing vancomycin, colistin, nystatin and trimethoprim (VCNT). A comparison with Gram-staining and immunofluorescence. Br J Vener Dis. 1972 Aug;48(4):287–292. doi: 10.1136/sti.48.4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Thin R. N., Barlow D., Eykyn S., Phillips I. Imported penicillinase producing Neisseria gonorrhoeae becomes endemic in London. Br J Vener Dis. 1983 Dec;59(6):364–368. doi: 10.1136/sti.59.6.364. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES